Rubicon Research IPO — Date, Price Band, GMP & Allotment 2025
Rubicon Research Limited is an India-based pharmaceutical company engaged in manufacturing and marketing of generic medicines, mainly for regulated markets like the US. The company focuses on value-added formulations and specialty products. It is coming up with an IPO to raise funds for business expansion, debt repayment, and general corporate purposes. The IPO will help the company strengthen its market presence and improve financial position going forward.
IPO Review
IPO GMP
IPO Subscription Subscription
Stock Price
As the IPO is listed, here is the Live Share Price for Rubicon Research
IPO Summary
What is the Rubicon Research IPO Timetable?
Track the IPO schedule and key events.
| Event | Date | Day |
|---|---|---|
| IPO Open Date | 09 Oct, 2025 | Thursday |
| IPO Close Date | 13 Oct, 2025 | Monday |
| Basis of Allotment | 14 Oct, 2025 | Tuesday |
| Refunds Initiated | 15 Oct, 2025 | Wednesday |
| Credit to Demat | 15 Feb, 2026 | Sunday |
| Listing Date | 16 Oct, 2025 | Thursday |
What is the Rubicon Research IPO Lot Size?
Bidding in multiples of 30 shares.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 30 | ₹14,550 |
| Retail (Max) | 13 | 390 | ₹1,89,150 |
| S-HNI (Min) | 14 | 420 | ₹2,03,700 |
| S-HNI (Max) | 68 | 2040 | ₹9,89,400 |
| B-HNI (Min) | 69 | 2070 | ₹10,03,950 |
About Rubicon Research
The company offers a range of pharmaceutical products, including oral solids, injectables, and other specialty formulations, targeting therapeutic segments such as central nervous system (CNS), cardiovascular, and oncology. Rubicon Research is promoted by experienced professionals with deep industry expertise, who have played a key role in shaping its growth strategy and global presence. Its business model is driven by product development partnerships, contract manufacturing, and direct sales in key markets, enabling it to generate revenue through both proprietary products and collaborations with global pharmaceutical companies.
Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.
Rubicon Research Key Performance Indicators (KPIs)
Objects of the Issue
| Issue Object | Estimate Amount |
|---|---|
Company Financials
The Rubicon Research company's financial performance (in ₹ Cr.) is summarized below:
| Metric | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue | 356.95 | 1,296.22 | 872.39 |
| OPM % | 19.9 | 18.1 | |
| EBITDA | 79.74 | 267.89 | 173.09 |
| Net Profit | 43.30 | 134.36 | 91.01 |
| Debt | 495.78 | 393.17 | 396.41 |
| Assets | 1,647.60 | 1,451.43 | 1,109.49 |
See how this IPO compares — view listing performance of all mainboard IPOs.
Promoters and Shareholding Details
| Particular | % Share |
|---|---|
| Promoter Holding Pre Issue | 15,44,37,251 |
| Promoter Holding Post Issue | 16,47,50,309 |
Frequently Asked Questions
What is the GMP of Rubicon Research?
The current Grey Market Premium (GMP) of Rubicon Research is ₹ 0.
What is the Rubicon Research IPO Price Band?
The price band for Rubicon Research IPO is ₹461 to ₹485.
When is the Rubicon Research IPO Allotment?
The allotment date for Rubicon Research IPO is October 14, 2025.
How to check Rubicon Research IPO Allotment Status?
You can check the allotment status on the IPO Allotment Status page or on the registrar's website .
Official Documents
Company Contact Details
Rubicon Research
Discussion 0
No comments yet
Be the first to share your thoughts!